VIRTUAL: Controversies in the Diagnosis and Management of Ocular Surface Tumors featuring Kathryn Colby, MD, PhD
3.0 Hour(s) of CME
Cornea/Anterior Segment Zoom Symposium
4:00-5:00 pm - Case Presentation by Dr. Kathryn Colby to Residents
5:00-6:00 pm - Cornea Cases Presented to Dr. Colby by staff from U of MN, Mayo, and Minnesota Eye Consultants
6:00-6:30 pm - MAO Social
6:30-7:30 pm - Controversies in the Diagnosis and Management of Ocular Surface Tumors featuring Kathryn Colby, MD, PhD
Dr. Colby specializes in the treatment of complex diseases of the cornea and ocular surface, including ocular surface tumors, keratoprosthesis (artificial cornea replacement), and corneal infections. She pioneered a minimally invasive treatment for Fuchs’ dystrophy, a common corneal condition mostly diagnosed in women, that leads to blurred vision and loss of sight. The technique, called Descemet stripping, removes a thin layer of damaged tissue to allow for tissue regeneration. It presents an alternative to corneal transplantation and local immunosuppression treatment for many who are diagnosed with the disease.
She was also involved in the pivotal clinical trial of the Implantable Miniature Telescope (VisionCare), the first U.S. Food and Drug Administration (FDA)–approved device to restore vision for advanced age-related macular degeneration, and determined the optimal surgical technique for placement of the device.
A prolific clinical investigator, Dr. Colby has presented numerous times nationally and internationally, and has authored nearly 100 scientific studies, contributed 2 dozen book chapters, and written 7 books. Additionally, she has held leadership roles in a number of national and international societies, including the American Academy of Ophthalmology, and currently serves as president of the Cornea Society.